@article{Dale_C-2022_83210,
title = {The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication data},
author = {Dale, C. and Takhar, R. and Carragher, R. and Torabi, F. and Katsoulis, M. and Duffield, S. and Kent, S. and Mueller, T. and Kurdi, A. and McTaggart, S. and Abbasizanjani, H. and Hollings, S. and Scourfield, A. and Lyons, R. and Griffiths, R. and Lyons, J. and Davies, G. and Harris, D. and Handy, A. and Mizani, M. and Tomlinson, C. and Ashworth, M. and Denaxas, S. and Banerjee, A. and Sterne, J. and Lovibond, K. and Brown, P. and Bullard, I. and Priedon, R. and Mamas, M. and Slee, A. and Lorgelly, P. and Pirmohamed, M. and Khunti, K. and Sattar, N. and Morris, A. and Sudlow, C. and Akbari, A. and Bennie, M. and Sofat, R.},
month = {jan},
year = {2022},
abstract = {ObjectivesTo estimate the impact of the COVID-19 pandemic on cardiovascular disease (CVD) and CVD management using routinely collected medication data as a proxy.},
journal = {MedRxiv},
publisher = {medRxiv},
url = {https://doi.org/10.1101/2021.12.31.21268587},
}
